Expression of ATP-Binding cassette membrane transporters in rodent and human sertoli cells: Relevance to the permeability of antiretroviral therapy at the blood-testis barrier

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 1, 2012, Pages 96-108

  Robillard, Kevin R ^a   Hoque, Md Tozammel ^a   Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,7 BIS(CARBOXYETHYL) 6 CARBOXYFLUORESCEIN; ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; BREAST CANCER RESISTANCE PROTEIN; CYCLOSPORIN A; DARUNAVIR; EFAVIRENZ; ELACRIDAR; EMTRICITABINE; GLYCOPROTEIN P; LOPINAVIR; MARAVIROC; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; MULTIDRUG RESISTANCE PROTEIN 1B; MULTIDRUG RESISTANCE PROTEIN 4; QUINIDINE; RALTEGRAVIR; RHODAMINE 6G; RITONAVIR; SAQUINAVIR; TENOFOVIR; UNCLASSIFIED DRUG; VALSPODAR; VERLUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TESTIS BARRIER; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PENETRATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SERTOLI CELL;

ANIMALS; ANTI-HIV AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-TESTIS BARRIER; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DNA, COMPLEMENTARY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PERMEABILITY; POLYMERASE CHAIN REACTION; RNA; SERTOLI CELLS;

EID: 84055213521     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.186916     Document Type: Article

References (41)

1. Augustine LM, Markelewicz RJ Jr, Boekelheide K, and Cherrington NJ (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33:182-189. (Pubitemid 40023530)
2. Bart J, Hollema H, Groen HJ, de Vries EG, Hendrikse NH, Sleijfer DT, Wegman TD, Vaalburg W, and van der Graaf WT (2004) The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 40:2064-2070. (Pubitemid 39165539)
3. Bendayan R, Lee G, and Bendayan M (2002) Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 57:365-380. (Pubitemid 34579217)
4. Bendayan R, Ronaldson PT, Gingras D, and Bendayan M (2006) In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 54:1159-1167. (Pubitemid 44434719)
5. Choo EF, Leake B, Wandel C, Imamura H, Wood AJ, Wilkinson GR, and Kim RB (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos 28:655-660. (Pubitemid 30390404)
6. Chui K, Trivedi A, Cheng CY, Cherbavaz DB, Dazin PF, Huynh AL, Mitchell JB, Rabinovich GA, Noble-Haeusslein LJ, and John CM (2011) Characterization and functionality of proliferative human sertoli cells. Cell Transplant 20:619-635.
7. Cruciani M, Liuzzi G, Chirianni A, Audagnotto S, Bonora S, Di Biagio A, Sinicco A, Bassetti M, and Gatti G (2006) Penetration of didanosine in semen of HIV-1-infected men. J Antimicrob Chemother 57:1244-1247. (Pubitemid 44644435)
8. Dahl V, Josefsson L, and Palmer S (2010) HIV reservoirs, latency, and reactivation: prospects for eradication. Antiviral Res 85:286-294.
9. Dallas S, Ronaldson PT, Bendayan M, and Bendayan R (2004a) Multidrug resistance protein 1-mediated transport of saquinavir by microglia. Neuroreport 15:1183-1186. (Pubitemid 38670077)
10. Dallas S, Schlichter L, and Bendayan R (2004b) Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl) adenine by microglia. J Pharmacol Exp Ther 309:1221-1229. (Pubitemid 38669713)
11. Dallas S, Zhu X, Baruchel S, Schlichter L, and Bendayan R (2003) Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther 307:282-290. (Pubitemid 37151919)
12. Enokizono J, Kusuhara H, Ose A, Schinkel AH, and Sugiyama Y (2008) Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Dispos 36:995-1002. (Pubitemid 351717455)
13. Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, and Saito H (2009) P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines. Biol Pharm Bull 32:1588-1593.
14. Ghosn J, Chaix ML, Peytavin G, Rey E, Bresson JL, Goujard C, Katlama C, Viard JP, Tréluyer JM, and Rouzioux C (2004) Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. AIDS 18:1958-1961. (Pubitemid 39313214)
15. Gupta A, Zhang Y, Unadkat JD, and Mao Q (2004) HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J Pharmacol Exp Ther 310:334-341. (Pubitemid 38812728)
16. Haimeur A, Conseil G, Deeley RG, and Cole SP (2004) The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21-53. (Pubitemid 38294344)
17. Imai T, Kawai Y, Tadokoro Y, Yamamoto M, Nishimune Y, and Yomogida K (2004) In vivo and in vitro constant expression of GATA-4 in mouse postnatal Sertoli cells. Mol Cell Endocrinol 214:107-115. (Pubitemid 38210120)
18. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, and Wilkinson GR (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289-294. (Pubitemid 28067324)
19. Kis O, Robillard K, Chan GN, and Bendayan R (2010a) The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci 31:22-35.
20. Kis O, Zastre JA, Ramaswamy M, and Bendayan R (2010b) pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions. J Pharmacol Exp Ther 334:1009-1022.
21. Kodaira H, Kusuhara H, Ushiki J, Fuse E, and Sugiyama Y (2010) Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J Pharmacol Exp Ther 333:788-796.
22. Lee G, Babakhanian K, Ramaswamy M, Prat A, Wosik K, and Bendayan R (2007) Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Pharm Res 24:1262-1274. (Pubitemid 46870591)
23. 4 and structurally related conjugates. J Biol Chem 269:27807-27810.
24. Mather JP (1980) Establishment and characterization of two distinct mouse testicular epithelial cell lines. Biol Reprod 23:243-252.
25. Meaden ER, Hoggard PG, Newton P, Tjia JF, Aldam D, Cornforth D, Lloyd J, Williams I, Back DJ, and Khoo SH (2002) P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals. J Antimicrob Chemother 50:583-588. (Pubitemid 35214800)
26. Melaine N, Liénard MO, Dorval I, Le Goascogne C, Lejeune H, and Jégou B (2002) Multidrug resistance genes and P-glycoprotein in the testis of the rat, mouse, guinea pig, and human. Biol Reprod 67:1699-1707. (Pubitemid 35387998)
27. Ni Z, Bikadi Z, Rosenberg MF, and Mao Q (2010) Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 11:603-617.
28. Panel on Antiretroviral Guidelines for Adults and Adolescents (2011) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, US Department of Health and Human Services, Washington, DC.
29. Pereira AS, Smeaton LM, Gerber JG, Acosta EP, Snyder S, Fiscus SA, Tidwell RR, Gulick RM, Murphy RL, and Eron JJ Jr (2002) The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850). J Infect Dis 186:198-204. (Pubitemid 34765507)
30. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Köck K, and Kroemer HK (2005) Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 37:253-278. (Pubitemid 40250291)
31. Ronaldson PT, Ashraf T, and Bendayan R (2010) Regulation of multidrug resistance protein 1 by tumor necrosis factor α in cultured glial cells: involvement of nuclear factor-κB and c-Jun N-terminal kinase signaling pathways. Mol Pharmacol 77:644-659.
32. Ronaldson PT, Lee G, Dallas S, and Bendayan R (2004) Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. Pharm Res 21:811-818. (Pubitemid 39011305)
33. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, and Borst P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705.
34. Storch CH, Theile D, Lindenmaier H, Haefeli WE, and Weiss J (2007) Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochem Pharmacol 73:1573-1581. (Pubitemid 46527547)
35. Su L, Cheng CY, and Mruk DD (2009) Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood-testis barrier. Int J Biochem Cell Biol 41:2578-2587.
36. Su L, Mruk DD, Lee WM, and Cheng CY (2011) Drug transporters and blood-testis barrier function. J Endocrinol 209:337-351.
37. Taylor S, Back DJ, Workman J, Drake SM, White DJ, Choudhury B, Cane PA, Beards GM, Halifax K, and Pillay D (1999) Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS 13:859-860. (Pubitemid 29224590)
38. van Leeuwen E, Ter Heine R, van der Veen F, Repping S, Beijnen JH, and Prins JM (2007) Penetration of atazanavir in seminal plasma of men infected with human immunodeficiency virus type 1. Antimicrob Agents Chemother 51:335-337. (Pubitemid 46047724)
39. van Praag RM, van Heeswijk RP, Jurriaans S, Lange JM, Hoetelmans RM, and Prins JM (2001) Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1. Clin Infect Dis 33:e91-e92.
40. Weiss J, Rose J, Storch CH, Ketabi-Kiyanvash N, Sauer A, Haefeli WE, and Efferth T (2007) Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother 59:238-245. (Pubitemid 47072063)
41. Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, and Bendayan R (2009) Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 87:1023-1036.